Stock Market Reviews

HKPD (Hong Kong Pharma Digital Technology Holdings Limited) News

Get the latest news, insights, and market updates on HKPD (Hong Kong Pharma Digital Technology Holdings Limited). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
  HONG KONG, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter (“OTC”) pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced that it received a notification letter (the “Notification Letter”) dated January 12, 2026 from Nasdaq's Listing Qualifications Department indicating that the closing bid price of the Company's class A ordinary shares of par value of US$0.001 each was bel
  Jan 16, 2026 - $HKPD
• Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders
  HONG KONG, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ: HKPD) ("HKPD" or the "Company"), a leading provider of over the counter (“OTC”) pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced that all proposals at the Company's 2025 annual meeting of stockholders held on December 12, 2025 local time were duly passed. The shareholders of the Company passed and approved the following proposals: Proposal No. 1: Th
  Dec 17, 2025 - $HKPD
• One Hong Kong Pharma Digital Technology Holdings Insider Raised Their Stake In The Previous Year
  Looking at Hong Kong Pharma Digital Technology Holdings Limited's ( NASDAQ:HKPD ) insider transactions over the last...
  Nov 29, 2025 - $HKPD
• Wall Street Set to Open Higher Friday; Nonfarm Payrolls Fall Well Short of Forecasts
  US stocks look set to open higher in Friday's trading session as investors parse key jobs data showi
  Sep 5, 2025 - $HKPD
• Is Hong Kong Pharma Digital Technology Holdings Limited's (NASDAQ:HKPD) 36% ROE Better Than Average?
  One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
  Apr 15, 2025 - $HKPD
• Hong Kong Pharma Digital Technology Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2024
  Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ: HKPD) ("HKPD" or the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced its unaudited financial results for the six months ended September 30, 2024.
  Mar 28, 2025 - $HKPD
• Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering
  Hong Kong Pharma Digital Technology Holdings Limited ("Hong Kong Pharma" or the "Company"), a leading provider of OTC pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced the pricing of its initial public offering (the "Offering") of an aggregate of 1,403,685 ordinary shares of par value $0.001 per share (the "Ordinary Shares"), at a public offering price of US$4.00 per share, of which 1,000,000 Ordinary Shares are offered by Hong Kong Pharma and 403,685 Ord
  Jan 23, 2025 - $HKPD
• Opening Day: Oilfield services provider Flowco jumps in market debut
  Shares of oilfield services provider Flowco jumped in their market debut on Thursday, as they opened for trading 21% above their IPO price. LATEST IPOS AND DIRECT LISTINGS: Flowco (FLOC) opened on January 16 at $29.00. The provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry had priced its initial public offering of 17.8M shares of its Class A common stock at a public offering price of $24.00 per share. PicoCELA (PCLA) opened o
  Jan 21, 2025 - $HKPD
• Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering
  Hong Kong Pharma Digital Technology Holdings Limited ("Hong Kong Pharma" or the "Company") (NASDAQ: HKPD), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced the closing of its initial public offering (the "Offering") of an aggregate of 1,403,685 ordinary shares, par value $0.001 per share (the "Ordinary Shares") at a public offering price of US$4.00 per share of which 1,000,000 Ordinary Shares were offered by
  Jan 16, 2025 - $HKPD